San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

'Celebrity' Endorsement Boosts Isis Stock Price

Shares of Isis Pharmaceuticals Inc. soared to a record high the morning of December 19 following an endorsement by financial personality and former hedge fund manager Jim Cramer.

Royal Philips to Buy Volcano Corp. for $1 Billion

BIOTECH: S.D. Company’s Imaging Prowess Draws Buyer

Royal Philips NV agreed to buy San Diego-based Volcano Corp. for $1 billion to expand catheter-based imaging of the heart and blood vessels as part of a wider refocus on more profitiable markets, such as medical gear.

MEI Pharma Raises $46 Million in Public Offering

MEI Pharma Inc., a clinical-stage oncology company, announced that it has raised about $46 million from the sale of 11.5 million shares of its common stock.

Tease photo

AMN Healthcare to Acquire 3 Brands From OGH LLC

AMN Healthcare Services Inc., a San Diego-based health care staffing company, announced an agreement to acquire Onward Healthcare, Locum Leaders and Medefis from OGH LLC for $82.5 million.

Tease photo

Halozyme Therapeutics, Janssen Biotech Sign Agreement

Halozyme Therapeutics Inc., a San Diego-based biopharmaceutical company, will receive $15 million as an initial payment from Pennsylvania-based Janssen Biotech Inc. as part of a collaboration and license agreement to develop and commercialize products combining Halozyme’s technology with Janssen’s compounds.

Royal Philips NV Buys Volcano Corp. for $1 Billion

Royal Philips NV agreed to buy San Diego-based Volcano Corp. for $1 billion to expand in catheter-based imaging of the heart and blood vessels as part of a wider refocus on more profitable markets, such as medical gear.

Rock My World Adds New Feature to Music App

Downtown-based Rock My World has trotted out a new feature on its RockMyRun music app for iPhones — one that plays tunes in synch with a listener’s heartbeat.

Tease photo

Steve Martin Appointed CFO of Applied Proteomics Inc.

Applied Proteomics Inc., a San Diego-based developer of protein-based molecular diagnostics, announced the appointment of Steve R. Martin as chief financial officer.

Biocept Inc. Granted Patent by South Korea

San Diego-based Biocept Inc., a molecular oncology diagnostics company, announced that it has been granted a patent in South Korea for its microfluidic channel technology used to capture circulating tumor cells.

Tease photo

Medical Records Portals Help Patients and Providers

Due to rising consumer interest in health information technology and the transition to accountable care inspired by health care reform - patient portals are everywhere.

Sharp Contracts With Geneva For Cardiac Platform

Geneva Health Care Inc., a San Diego-based medical technology company, announced that Sharp HealthCare will begin using the Geneva Healthcare Suite, a technology platform for managing data from cardiac devices.

Organovo Partners With Yale for Tissue Creation

BIOTECH: Efforts Backed By Grant From a Foundation

San Diego 3-D bioprinting company Organovo Holdings Inc. and Yale School of Medicine, Department of Surgery have formed a collaboration to develop bioprinted tissues for surgical transplantation research, according to a recent news release.

Tease photo

‘Sweat Equity’

BIOTECH: Dehydration Detection Is Leading Co. To Other Types of Sensors

Electrozyme LLC, a local startup that has attracted the financial support of Dallas Mavericks owner Mark Cuban, has developed a technology for fitness-related wearable devices that will tell users when they are nearing dehydration — and what to do about it.

Batu Biologics Files Investigational Drug App With FDA

Batu Biologics Inc., a biotechnology company developing a cancer vaccine that targets a tumor's blood vessels, announced the filing of an Investigational Drug Application (IND) with the U.S. Food and Drug Administration (FDA) for its lead immune therapy, ValloVax.

MEI Pharma Inc. Announces $45 Million Proposed Public Offering

MEI Pharma Inc., a San Diego-based oncology company focused on clinical development of cancer therapies, announced that it plans to offer up to $45 million in shares of its common stock in an underwritten public offering.